I agree that this site is using cookies. You can find further informations here.
X
Seufert, Jochen
277  results:
Search for persons X
?
1

Kontinuierliche Glukosemessung bei Menschen mit Typ-2-Diabe..:

Seufert, Jochen ; Dänschel, Ingrid ; Gölz, Stefan...
Diabetologie und Stoffwechsel.  , 2024
Link: https://doi.org/10.1055/..
 
?
2

Effects of canagliflozin on total heart failure events acro..:

Vaduganathan, Muthiah ; Cannon, Christopher P. ; Jardine, Meg J....
European Journal of Heart Failure.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

Management of pasireotide-induced hyperglycemia in patients..:

Störmann, Sylvère ; Meyhöfer, Sebastian M. ; Groener, Jan B....
Frontiers in Endocrinology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
4

Effective management of recurrent Doege–Potter syndrome wit..:

Schöler, Felix ; Storz, Maximilian Andreas ; Khavaran, Ashkan...
Cancer Reports.  7 (2024)  3 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
5

Real‐life effectiveness of iGlarLixi (insulin glargine 100 ..:

Seufert, Jochen ; Freemantle, Nick ; Guja, Cristian...
Diabetes, Obesity and Metabolism.  26 (2024)  7 - p. 2988-2992 , 2024
Link: https://doi.org/10.1111/..
 
?
6

Reduced bone mineral density is associated to post-TIPS sur..:

Reincke, Marlene ; Seufert, Jochen ; Laubner, Katharina...
Digestive and Liver Disease.  , 2024
Link: https://doi.org/10.1016/..
 
?
7

Continuous glucose monitoring for the routine care of type ..:

Ajjan, Ramzi A. ; Battelino, Tadej ; Cos, Xavier...
Nature Reviews Endocrinology.  20 (2024)  7 - p. 426-440 , 2024
Link: https://doi.org/10.1038/..
 
?
8

Effects of canagliflozin on cardiovascular and kidney event..:

Yi, Tae Won ; Wong, Michelle M.Y. ; Neuen, Brendon L....
Diabetes, Obesity and Metabolism.  25 (2023)  7 - p. 2043-2047 , 2023
Link: https://doi.org/10.1111/..
 
?
9

iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is ..:

Guja, Cristian ; Kis, János Tibor ; Haluzík, Martin...
Diabetes, Obesity and Metabolism.  25 (2023)  6 - p. 1723-1730 , 2023
Link: https://doi.org/10.1111/..
 
?
10

Cardiovascular and kidney outcomes with canagliflozin accor..:

Tsoukas, Michael A. ; Woo, Vincent ; Tobe, Sheldon W....
Diabetes, Obesity and Metabolism.  25 (2023)  7 - p. 2038-2042 , 2023
Link: https://doi.org/10.1111/..
 
?
11

Patient perspectives and experiences with basal insulin tit..:

Harris, Stewart B. ; Mohammedi, Kamel ; Bertolini, Monica...
Diabetes, Obesity and Metabolism.  25 (2023)  5 - p. 1408-1412 , 2023
Link: https://doi.org/10.1111/..
 
?
12

Identification of predictive factors of diabetic ketoacidos..:

Ibald‐Mulli, Angela ; Seufert, Jochen ; Grimsmann, Julia M....
Diabetes, Obesity and Metabolism.  25 (2023)  7 - p. 1823-1829 , 2023
Link: https://doi.org/10.1111/..
 
?
13

Tirzepatid: GIP-/GLP-1-Rezeptoragonist zur Therapie des Typ..:

Aberle, Jens ; Forst, Thomas ; Heitmann, Elke..
Diabetologie und Stoffwechsel.  18 (2023)  6 - p. 461-474 , 2023
Link: https://doi.org/10.1055/..
 
?
14

An analysis of DPV and DIVE registry patients with chronic ..:

Bramlage, Peter ; Lanzinger, Stefanie ; Mühldorfer, Steffen...
Cardiovascular Diabetology.  22 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
15

Effectiveness and Safety of iGlarLixi (Insulin Glargine 100..:

Haluzík, Martin ; Seufert, Jochen ; Guja, Cristian...
Diabetes Therapy.  14 (2023)  4 - p. 639-652 , 2023
Link: https://doi.org/10.1007/..
 
1-15